These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11925882)

  • 1. [Immunological tolerance and rejection after hematopoietic stem cell transplantation].
    Ikehara S
    Rinsho Ketsueki; 2002 Feb; 43(2):89-93. PubMed ID: 11925882
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of naturally arising regulatory T cells in hematopoietic cell transplantation.
    Nguyen VH; Zeiser R; Negrin RS
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):995-1009. PubMed ID: 17084366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing role of natural killer cells in solid organ rejection and tolerance.
    Kitchens WH; Uehara S; Chase CM; Colvin RB; Russell PS; Madsen JC
    Transplantation; 2006 Mar; 81(6):811-7. PubMed ID: 16570001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology. Gently soothing a savage immune system.
    Couzin J
    Science; 2002 Apr; 296(5567):456-8. PubMed ID: 11964457
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation by mesenchymal stem cells and clinical experience.
    Le Blanc K; Ringdén O
    J Intern Med; 2007 Nov; 262(5):509-25. PubMed ID: 17949362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Stealth immune tolerance" in stem cell transplantation: potential for "universal donors" in myocardial regenerative therapy.
    Chiu RC
    J Heart Lung Transplant; 2005 May; 24(5):511-6. PubMed ID: 15896746
    [No Abstract]   [Full Text] [Related]  

  • 8. Tolerance induction using bone marrow transplantation.
    Ascher NL
    Liver Transpl Surg; 1998 Jul; 4(4):335-6. PubMed ID: 9649649
    [No Abstract]   [Full Text] [Related]  

  • 9. Infusion of donor-derived hematopoietic stem cells in organ transplantation: clinical data.
    De Pauw L; Toungouz M; Goldman M
    Transplantation; 2003 May; 75(9 Suppl):46S-49S. PubMed ID: 12819491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation.
    Wolff SN
    Bone Marrow Transplant; 2002 Apr; 29(7):545-52. PubMed ID: 11979301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance strategies for stem-cell-based therapies.
    Chidgey AP; Layton D; Trounson A; Boyd RL
    Nature; 2008 May; 453(7193):330-7. PubMed ID: 18480814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation recent advances in transplantation immunology.
    Gluckman E
    Curr Opin Immunol; 2006 Oct; 18(5):556-8. PubMed ID: 16893635
    [No Abstract]   [Full Text] [Related]  

  • 13. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance induction in clinical transplantation.
    Fehr T; Sykes M
    Transpl Immunol; 2004; 13(2):117-30. PubMed ID: 15380542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance and chronic rejection.
    Sayegh MH; Carpenter CB
    Kidney Int Suppl; 1997 Mar; 58():S11-4. PubMed ID: 9067936
    [No Abstract]   [Full Text] [Related]  

  • 16. Embryonic stem cell derived and adult hematopoietic stem cell transplantation for tolerance induction in a renal allograft recipient:--a case report.
    Trivedi HL; Mishra VV; Vanikar AV; Modi PR; Shah VR; Shah PR; Firoz A
    Transplant Proc; 2006 Nov; 38(9):3103-8. PubMed ID: 17112910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell recipients do not develop post-transplantation immune tolerance to antigens present on minimal residual disease.
    Natzke AM; Shaw JL; McKeller MR; Emo KL; Mullen CA
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):34-45. PubMed ID: 17222751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor bone marrow transplantation: chimerism and tolerance.
    Delis S; Ciancio G; Burke GW; Garcia-Morales R; Miller J
    Transpl Immunol; 2004; 13(2):105-15. PubMed ID: 15380541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cells.
    Reisner Y; Gur H; Reich-Zeliger S; Martelli MF; Bachar-Lustig E
    Ann N Y Acad Sci; 2005 Jun; 1044():70-83. PubMed ID: 15958699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second transplant for a thalassemia patient after graft rejection: with immunosuppression and allogeneic peripheral blood stem cell.
    Li CK; Shing MM; Chik KW; Lee V; Tsang KS; Yuen PM
    Pediatr Hematol Oncol; 2002 Jun; 19(4):267-71. PubMed ID: 12051594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.